Navigation Links
HeartWare Presentation at the Wells Fargo Securities 2013 Healthcare Conference to be Webcast
Date:6/13/2013

FRAMINGHAM, Mass. and SYDNEY, June 13, 2013 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR - ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the Wells Fargo Securities Research and Economics 2013 Healthcare Conference at 9:25 a.m. EDT on Tuesday, June 18, 2013.  The conference is being held June 18-19 at the The InterContinental Boston.

A live webcast of the Company's presentation at the conference will be available via a link provided at www.heartware.com.  A replay of the webcast will be available for 90 days at the site after the presentation.

About HeartWare International

HeartWare International develops and manufactures miniaturized implantable heart pumps, or ventricular assist devices, to treat Class IIIB / IV patients suffering from advanced heart failure. The HeartWare® Ventricular Assist System features the HVAD® pump, a small full-support circulatory assist device designed to be implanted next to the heart, avoiding the abdominal surgery generally required to implant competing devices. The HeartWare System is approved in the United States for the intended use as a bridge to cardiac transplantation in patients who are at risk of death from refractory end-stage left ventricular heart failure, has received CE Marking in the European Union and has been used to treat patients in 30 international countries. The device is also currently the subject of a U.S. clinical trial for destination therapy. For additional information, please visit the Company's website at www.heartware.com.

HeartWare International, Inc. is a member of the Russell 2000® and its securities are publicly traded on The NASDAQ Stock Market and the Australian Securities Exchange.

HEARTWARE, HVAD, MVAD and HeartWare logos are registered trademarks of HeartWare, Inc.

For further information:
Christopher Taylor
HeartWare International, Inc.
Email: ctaylor@heartwareinc.com 
Phone: +1 508 739 0864


'/>"/>
SOURCE HeartWare International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. HeartWare International Announces Intention To Delist From Australian Securities Exchange (ASX)
2. HeartWare Presentation At The Goldman Sachs 34th Annual Global Healthcare Conference To Be Webcast
3. HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast
4. HeartWare Presentation at the Bank of America Merrill Lynch 2013 Health Care Conference to be Webcast
5. HeartWare International Reports $49.2 Million In First Quarter 2013 Revenue; 87% Increase From First Quarter Of 2012
6. HeartWare Schedules First Quarter Conference Call And Webcast
7. HeartWare International, Inc. Announces Pricing of Public Offering of Common Stock
8. HeartWare International, Inc. Announces Public Offering of Common Stock
9. HeartWare Presentation at the Barclays Capital 2013 Global Healthcare Conference To Be Webcast
10. HeartWare Presentation At Raymond James 34th Annual Institutional Investors Conference To Be Webcast
11. HeartWare International Reports Fourth Quarter 2012 Revenue Of $32.7 Million; Full Year 2012 Revenue Of $110.9 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... bringing their 100% all-natural lice removal service to Brooklyn ... th Street was specifically chosen to make treatment convenient for ... is to ease parents, stress and bring their lives back under ... to class without skipping a beat. The best part is that ... family," Licenders President Adie Horowitz states. ...
(Date:12/6/2016)... LONDON , Dec. 6, 2016 Diabetes ... The diabetes and obesity disease cluster is currently ... (T1DM) and type 2 diabetes mellitus (T2DM), and the ... and quality of products, is attributable to these indications. ... a large market presence, there are a large number ...
(Date:12/6/2016)... , Dec. 6, 2016 Human Vaccines ... in-depth region wise and country wise analysis of ... include manufacturers of human vaccines products, raw material ... to enter the market. The report provides ... vaccines market. Qualitative analysis comprises market dynamics, trends, ...
Breaking Medicine Technology:
(Date:12/7/2016)... , ... December 07, 2016 , ... ... Dallas, Texas, is condemning "scam operations" carried out by unethical locksmith companies and ... scam operations to a halt. According to Texas Premier Locksmith, these fraudulent locksmith ...
(Date:12/7/2016)... Ohio (PRWEB) , ... December 07, 2016 , ... ... in the 2016 BOC Business Brilliance Awards under the Best New Product Launch ... and results achieved through user experience. , BOC Global Events & Training Group ...
(Date:12/7/2016)... ... 07, 2016 , ... “Tomorrow Trump Goes To Washington”: a brief but ... presidency and to America. “Tomorrow Trump Goes To Washington” is the creation of published ... for this country. , Nancy attributes her patriotic nature to her WWII veteran father. ...
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... ... the fifth annual Business Architecture Innovation Summit in Reston, VA on March 21-22, ... who will share a range of experiences from a cross-section of industries such ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... networks that can be seen on a type of MRI, according to a ... progressive disorder of the central nervous system characterized by tremors or trembling and ...
Breaking Medicine News(10 mins):